03 October 2014

Hyperphosphatemia Ppts and latest published articles



Hyperphosphatemia: Hyperphosphatemia is an electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood.

Chronic Kidney Disease
Sandeep Vetteth
https://www.utoledo.edu

Vascular Calcification
Kristina Boström, MD, PhD
https://www.mcdb.ucla.edu/VBTG/VascCalc_Bostrom.ppt

Hem/Onc Emergencies
Peter Newburger, MD, Venee Tubman, MD
https://www.umassmed.edu

The Cellular Environment: Fluids and Electrolytes, Acids and Bases
http://users.ipfw.edu

Dyatrophic Calcinosis
Dr Abdelaziz Elamin, MD, PhD
http://www.pitt.edu/

Functions of the Kidneys 
http://www.austincc.edu

Chronic Renal Failure
http://www.hsc.unt.edu

Regulation of Phosphate Transport in Proximal Tubule
Alexander Usorov, MD
http://medicine.med.nyu.edu

Nephrology Grand Rounds
http://medicine.med.nyu.edu

Minerals
Dr Reed Berger
https://www.uic.edu/depts/mcam/nutrition/ppt/Minerals1_add.ppt

Hem/Onc Emergencies
Saulius Girnius
http://www.bumc.bu.edu

Fluid, Electrolyte & Acid-Base Balance
http://academic.evergreen.edu

Polycystic Kidney Disease
http://www.smccd.net

Stressors Affecting
Fluid & Electrolyte Balance
K. Burger, MSEd, MSN, RN, CNE
http://www2.sunysuffolk.edu

Chronic Renal Failure
Matt Crowley, Doug Srygley , Vijay Reddy
https://vmw-lmsc.duhs.duke.edu

Electrolyte Abnormalities in the Hospitalized Patient
Cynthia Seitz MD
http://medicine.nevada.edu

Kidney Function & Disease
McCafferty
http://www.csuchico.edu

200 Latest Published articles of Hyperphosphatemia

1.    Hyperphosphatemia in a patient with Candida sepsis.
Dufour, D Robert
Clinical chemistry  Volume: 60   Issue: 9   Pages: 1241-2   Published: 2014-Sep

2.    Efficacy and safety of lanthanum carbonate in pre-dialysis CKD patients with hyperphosphatemia: a randomized trial.
Takahara, Yuki; Matsuda, Yoshimi; Takahashi, Shunichi; et al.
Clinical nephrology  Volume: 82   Issue: 3   Pages: 181-90   Published: 2014-Sep
  View Abstract

3.    Sucroferric Oxyhydroxide (Velphoro) for Hyperphosphatemia
[Anonymous]
MEDICAL LETTER ON DRUGS AND THERAPEUTICS  Volume: 56   Issue: 1449   Pages: 76-77   Published: AUG 18 2014

4.    Sucroferric oxyhydroxide (Velphoro) for hyperphosphatemia.
[Anonymous]
The Medical letter on drugs and therapeutics  Volume: 56   Issue: 1449   Pages: 76-7   Published: 2014-Aug-18

5.    Immobilization-Induced Hyperphosphatemia and Functional Hypoparathyroidism Successfully Treated With Oral Bisphosphonates
Trivedi, Disha D.; Gosmanova, Elvira O.; Wall, Barry M.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES  Volume: 348   Issue: 2   Pages: 179-180   Published: AUG 2014

6.    Dietary educational interventions for management of hyperphosphatemia in hemodialysis patients: a systematic review and meta-analysis
Karavetian, Mirey; de Vries, Nanne; Rizk, Rana; et al.
NUTRITION REVIEWS  Volume: 72   Issue: 7   Pages: 471-482   Published: JUL 2014
 from Publisher   View Abstract

7.    Severe Nonuremic Calciphylaxis Due to Hyperphosphatemia Resolving With Multimodality Treatment Including Phosphate Binders
Wanat, Karolyn A.; Stewart, Campbell L.; Negoianu, Dan; et al.
JAMA DERMATOLOGY  Volume: 150   Issue: 6   Pages: 671-673   Published: JUN 2014

8.    Treatment of Hyperphosphatemia With Bixalomer in Japanese Patients on Long-Term Hemodialysis With Gastrointestinal Symptoms
Ito, Kae; Takeshima, Akiko; Shishido, Kanji; et al.
THERAPEUTIC APHERESIS AND DIALYSIS  Volume: 18   Special Issue: SI   Supplement: 2   Pages: 19-23   Published: JUN 2014
 from Publisher   View Abstract

9.    Dose-Finding Study of Bixalomer in Patients With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia: A Double-Blind, Randomized, Placebo-Controlled and Sevelamer Hydrochloride-Controlled Open-Label, Parallel Group Study
Akizawa, Tadao; Origasa, Hideki; Kameoka, Chisato; et al.
THERAPEUTIC APHERESIS AND DIALYSIS  Volume: 18   Special Issue: SI   Supplement: 2   Pages: 24-32   Published: JUN 2014
 from Publisher   View Abstract

10.    A new missense mutation in FGF23 gene in a male with hyperostosis-hyperphosphatemia syndrome (HHS)
Abbasi, Farzaneh; Ghafouri-Fard, Soudeh; Javaheri, Mona; et al.
GENE  Volume: 542   Issue: 2   Pages: 269-271   Published: JUN 1 2014
 from Publisher   View Abstract

11.    What Can We Learn from the Saga of Chitosan Gums in Hyperphosphatemia Therapy?
Oh, Man S.; Uribarri, Jaime
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY  Volume: 9   Issue: 5   Pages: 967-970   Published: MAY 7 2014
 from Publisher   View Abstract

12.    LENGTH OF STAY AND MORTALITY IN HYPERPHOSPHATEMIA PATIENTS ADMINISTERED PHOSPHATE BINDERS COMPARED WITH MATCHED CONTROLS
Belk, K. W.; Craver, C. W.
VALUE IN HEALTH  Volume: 17   Issue: 3   Pages: A291-A291   Meeting Abstract: PUK7   Published: MAY 2014

13.    SYSTEMATIC REVIEW AND META-ANALYSIS OF SEVELAMER VERSUS CALCIUM-BASED BINDERS FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE
Patel, Leena; Bernard, Lisa M.; Elder, Grahame J.
NEPHROLOGY DIALYSIS TRANSPLANTATION  Volume: 29   Supplement: 3   Pages: 148-148   Meeting Abstract: SP231   Published: MAY 2014

14.    LANTHANUM CARBONATE FOR HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE BEFORE AND DURING DIALYSIS: ACOST-EFFECTIVENESS ANALYSIS IN SPAIN
Gros, Blanca; Galan, Antonio; Gonzalez-Parra, Emilio; et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION  Volume: 29   Supplement: 3   Pages: 270-271   Meeting Abstract: SP595   Published: MAY 2014

15.    HYPERPHOSPHATEMIA IS A RISK FACTOR OF ACCELERATED DECLINE IN RENAL FUNCTION IN CAPD PATIENTS
Kuo Li-Chueh; Hwang Jyh-Chang; Cheng Ben-Chung; et al.
NEPHROLOGY  Volume: 19   Special Issue: SI   Supplement: 2   Pages: 151-151   Published: MAY 2014

16.    ISOLATED PARAPROTEINEMIA CAUSING SPURIOUS HYPERPHOSPHATEMIA
Aggarwal, Aakash; Bhardwaj, Rahul
AMERICAN JOURNAL OF KIDNEY DISEASES  Volume: 63   Issue: 5   Pages: A21-A21   Meeting Abstract: 12   Published: MAY 2014

17.    HYPERPHOSPHATEMIA WITH HIGH FIBROBLAST GROWTH FACTOR 23: A COMPLEX GENETIC DISORDER
Raina, R.; Hanley, P.; Lou, Linda; et al.
AMERICAN JOURNAL OF KIDNEY DISEASES  Volume: 63   Issue: 5   Pages: A93-A93   Meeting Abstract: 298   Published: MAY 2014

18.    Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles
Locatelli, Francesco; Del Vecchio, Lucia; Violo, Leano; et al.
EXPERT OPINION ON DRUG SAFETY  Volume: 13   Issue: 5   Pages: 551-561   Published: MAY 2014
 from Publisher   View Abstract

19.    Effects of three blood purification methods on serum fibroblast growth factor-23 clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis
Miao, Li-Ying; Zhu, Bin; He, Xiao-Zhou; et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE  Volume: 7   Issue: 4   Pages: 947-952   Published: APR 2014
 from Publisher   View Abstract

20.    Randomized Controlled Trial of Bixalomer Versus Sevelamer Hydrochloride in Hemodialysis Patients With Hyperphosphatemia
Akizawa, Tadao; Origasa, Hideki; Kameoka, Chisato; et al.
Group Author(s): Bixalomer Study Grp
THERAPEUTIC APHERESIS AND DIALYSIS  Volume: 18   Issue: 2   Pages: 122-131   Published: APR 2014
 from Publisher   View Abstract

21.    Spurious hyperphosphatemia in a case of multiple myeloma.
Chakraborty, Sutirtha; Sen, Susruta; Gupta, Debkishore; et al.
Indian journal of clinical biochemistry : IJCB  Volume: 29   Issue: 2   Pages: 250-2   Published: 2014-Apr (Epub 2013 Aug 08)
 from Publisher   View Abstract

22.    Ferric Citrate Hydrate for the Treatment of Hyperphosphatemia in Nondialysis-Dependent CKD
Yokoyama, Keitaro; Hirakata, Hideki; Akiba, Takashi; et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY  Volume: 9   Issue: 3   Pages: 543-552   Published: MAR 7 2014
 from Publisher   View Abstract

23.    Dietary Trends and Management of Hyperphosphatemia Among Patients With Chronic Kidney Disease: An International Survey of Renal Care Professionals
Fouque, Denis; Cruz Casal, Maria; Lindley, Elizabeth; et al.
JOURNAL OF RENAL NUTRITION  Volume: 24   Issue: 2   Pages: 110-115   Published: MAR 2014
 from Publisher   View Abstract

24.    Correction of hyperphosphatemia suppresses cardiac remodeling in uremic rats
Yamazaki-Nakazawa, Ai; Mizobuchi, Masahide; Ogata, Hiroaki; et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY  Volume: 18   Issue: 1   Pages: 56-64   Published: FEB 2014
 from Publisher   View Abstract

25.    Efficacy and tolerability of lanthanum carbonate in treatment of hyperphosphatemia patients receiving dialysis - a systematic review and meta-analysis of randomized controlled trials
Huang, Wenhui; Liu, Jing; Tang, Yu; et al.
CURRENT MEDICAL RESEARCH AND OPINION  Volume: 30   Issue: 1   Pages: 99-108   Published: JAN 2014
 from Publisher   View Abstract

26.    Hyperphosphatemia and phosphate binders: effectiveness and safety
Kalaitzidis, Rigas G.; Elisaf, Moses S.
CURRENT MEDICAL RESEARCH AND OPINION  Volume: 30   Issue: 1   Pages: 109-112   Published: JAN 2014
 from Publisher   View Abstract

27.    The role of short daily hemodialysis in the control of hyperphosphatemia, secondary hyperparathyroidism and anemia
Jiang, Jie-Long; Ren, Wei; Li, Yan; et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY  Volume: 45   Issue: 6   Pages: 1725-1731   Published: DEC 2013
 from Publisher   View Abstract

28.    Long-Term Treatment of Hyperphosphatemia With Bixalomer in Japanese Hemodialysis Patients
Akizawa, Tadao; Kameoka, Chisato; Kaneko, Yuichiro; et al.
Group Author(s): Bixalomer Study Grp
THERAPEUTIC APHERESIS AND DIALYSIS  Volume: 17   Issue: 6   Pages: 612-619   Published: DEC 2013
 from Publisher   View Abstract

29.    Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients
Streja, Elani; Lau, Wei Ling; Goldstein, Leanne; et al.
KIDNEY INTERNATIONAL SUPPLEMENTS  Volume: 3   Issue: 5   Pages: 462-468   Published: DEC 2013
 from Publisher   View Abstract

30.    Novel cyclodextrin nanosponges for delivery of calcium in hyperphosphatemia
Shende, Pravin; Deshmukh, Kiran; Trotta, Fransesco; et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS  Volume: 456   Issue: 1   Pages: 95-100   Published: NOV 1 2013
 from Publisher   View Abstract

31.    Correction of hypocalcemia allows optimal recruitment of FGF-23-dependent phosphaturic mechanisms in acute hyperphosphatemia post-phosphate enema
Gracia-Iguacel, Carolina; Gonzalez-Parra, Emilio; Rodriguez-Osorio, Laura; et al.
JOURNAL OF BONE AND MINERAL METABOLISM  Volume: 31   Issue: 6   Pages: 703-707   Published: NOV 2013
 from Publisher   View Abstract

32.    Use of nicotinamide to treat hyperphosphatemia in dialysis patients.
Lenglet, Aurelie; Liabeuf, Sophie; Guffroy, Pauline; et al.
Drugs in R&D  Volume: 13   Issue: 3   Pages: 165-73   Published: 2013-Sep
 from Publisher   View Abstract

33.    Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients
Ye, Zhong; Palazzo, Juan P.; Lin, Liz; et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY  Volume: 28   Issue: 9   Pages: 1469-1475   Published: SEP 2013
 from Publisher   View Abstract

34.    MANAGEMENT OF HYPERPHOSPHATEMIA IN HAEMODIALYSIS PATIENTS IN AN OUTER METROPOLITAN DIALYSIS UNIT: THE OPERATION PHOSPHATE AGGRESSIVE LOWERING (OPAL) PROJECT
Light, C.; Pikoos, A.; Kulkarni, H.
NEPHROLOGY  Volume: 18   Special Issue: SI   Supplement: 1   Pages: 63-64   Meeting Abstract: 192   Published: SEP 2013

35.    Hyperphosphatemia is associated with anemia in adults without chronic kidney disease: results from the National Health and Nutrition Examination Survey (NHANES): 2005-2010
Wojcicki, Janet M.
BMC NEPHROLOGY  Volume: 14     Article Number: 178   Published: AUG 21 2013
 from Publisher   View Abstract

36.    Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence
Covic, Adrian; Rastogi, Anjay
BMC NEPHROLOGY  Volume: 14     Article Number: 153   Published: JUL 18 2013
 from Publisher   View Abstract

37.    Massive hyperphosphatemia in a patient with neuronal intestinal dysplasia after bowel preparation with oral sodium phosphate
Arikan, Hakki; Guler, Derya; Birdal, Gurdal; et al.
RENAL FAILURE  Volume: 35   Issue: 6   Pages: 875-878   Published: 2013
 from Publisher   View Abstract

38.    Nicotinic Acid and Nicotinamide: A Review of Their Use for Hyperphosphatemia in Dialysis Patients
Rennick, Amanda; Kalakeche, Rabih; Seel, Lindsey; et al.
PHARMACOTHERAPY  Volume: 33   Issue: 6   Pages: 683-690   Published: JUN 2013
 from Publisher   View Abstract

39.    Role of hyperphosphatemia-mediated vascular calcification in cardiovascular outcomes and its management: a review
Latif, Faisal; Khalid, Muhammad Masood; Khan, Fahad; et al.
JOURNAL OF CARDIOVASCULAR MEDICINE  Volume: 14   Issue: 6   Pages: 410-415   Published: JUN 2013
 from Publisher   View Abstract

40.    [Pharmacological and clinical profile of bixalomer (Kiklin() capsules): a new therapeutic agent for hyperphosphatemia].
Taniguchi, Keiichi; Kakuta, Hirotoshi; Tomura, Yuichi; et al.
Nihon yakurigaku zasshi. Folia pharmacologica Japonica  Volume: 141   Issue: 6   Pages: 333-7   Published: 2013-Jun

41.    Low calcium dialysate combined with CaCO3 in hyperphosphatemia in hemodialysis patients
Gao, Zhuo; Lun, Li-De; Li, Xin-Lun
EXPERIMENTAL AND THERAPEUTIC MEDICINE  Volume: 5   Issue: 6   Pages: 1732-1736   Published: JUN 2013
 from Publisher   View Abstract

42.    Pharmacological and clinical profile of bixalomer (Kiklin (R) capsules): a new therapeutic agent for hyperphosphatemia
Taniguchi, Keiichi; Kakuta, Hirotoshi; Tomura, Yuichi; et al.
Folia Pharmacologica Japonica  Volume: 141   Issue: 6   Pages: 333-337   Published: JUN 2013

43.    LANTHANUM CARBONATE FOR HYPERPHOSPHATEMIA IN PATIENTS ON PERITONEAL DIALYSIS
Ohno, Michiya; Ohashi, Hiroshige; Oda, Hiroshi; et al.
PERITONEAL DIALYSIS INTERNATIONAL  Volume: 33   Issue: 3   Pages: 297-303   Published: MAY-JUN 2013
 from Publisher   View Abstract

44.    Dose-Response and Efficacy of Ferric Citrate to Treat Hyperphosphatemia in Hemodialysis Patients: A Short-term Randomized Trial
Dwyer, Jamie P.; Sika, Mohammed; Schulman, Gerald; et al.
Group Author(s): Collaborative Study Grp
AMERICAN JOURNAL OF KIDNEY DISEASES  Volume: 61   Issue: 5   Pages: 759-766   Published: MAY 2013
 from Publisher   View Abstract

45.    HYPERPHOSPHATEMIA INDUCES INTEGRIN LINKED KINASE EXPRESSION AND LEADS TO CELLULAR SENESCENCE AND AGING: STUDIES IN VIVO AND IN VITRO
Troyano Suarez, Nuria; Del Nogal Avila, Maria; Mora Valenciano, Ines; et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION  Volume: 28   Supplement: 1   Pages: 60-60   Published: MAY 2013

46.    HYPERPHOSPHATEMIA AS AN INDICATOR FOR INITIATING RENAL REPLACEMENT THERAPY
Lu, Yueh-An; Liu, Yen-Chun; Lee, Shen-Yang; et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION  Volume: 28   Supplement: 1   Pages: 156-157   Published: MAY 2013

47.    LOW DOSE NICOTINAMIDE AS AN ADJUNCTIVE THERAPY TO CALCIUM CARBONATE FOR CONTROL OF HYPERPHOSPHATEMIA IN HEMODIALYSIS PATIENTS
ElSharkawy, Magdy M. S.; Kamel, Mostafa; Elhamamsy, Manal; et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION  Volume: 28   Supplement: 1   Pages: 253-253   Published: MAY 2013

48.    DOSE RELATIVITY OF SEVELAMER HYDROCHLORIDE AND LANTHANUM CARBONATE UNDER REAL-WORLD CONDITIONS: IMPLICATIONS FOR MANAGEMENT OF PATIENTS WITH END-STAGE RENAL DISEASE AND HYPERPHOSPHATEMIA
Copley, J. B.; Wilson, R. J.; Keith, M. S.
VALUE IN HEALTH  Volume: 16   Issue: 3   Pages: A192-A192   Published: MAY 2013

49.    Does Hyperphosphatemia induce Monocyte Dysfunction in People with chronic Kidney Failure?
Luthe, A.; Zawada, A.; Seiler, S.; et al.
INTERNIST  Volume: 54   Supplement: 1   Pages: 47-48   Published: APR 2013

50.    PSUEDO HYPERPHOSPHATEMIA IN MULTIPLE MYELOMA
Kumar, Anshul; Dhakarwal, Pradeep; Agrawal, Vibha; et al.
AMERICAN JOURNAL OF KIDNEY DISEASES  Volume: 61   Issue: 4   Pages: A57-A57   Meeting Abstract: 166   Published: APR 2013

51.    [Recognition for treating chronic renal failure hyperphosphatemia by Chinese medicine and pharmacy].
Bi, Li-ming; Gao, Jun; Zhu, Dong-yun
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban  Volume: 33   Issue: 3   Pages: 425-7, 431   Published: 2013-Mar

52.    Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients
Hutchison, Alastair J.; Gill, Maggie; Copley, J. Brian; et al.
BMC NEPHROLOGY  Volume: 14     Article Number: 40   Published: FEB 18 2013
 from Publisher   View Abstract

53.    Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China
Xu, Jing; Zhang, Yi-Xiang; Yu, Xue-Qing; et al.
BMC NEPHROLOGY  Volume: 14     Article Number: 29   Published: FEB 4 2013
 from Publisher   View Abstract

54.    Adherence to Phosphate Binder Therapy Is the Primary Determinant of Hyperphosphatemia Incidence in Patients Receiving Peritoneal Dialysis
Hung, Kai-Yin; Liao, Shang-Chih; Chen, Tzu-Hsiu; et al.
THERAPEUTIC APHERESIS AND DIALYSIS  Volume: 17   Issue: 1   Pages: 72-77   Published: FEB 2013
 from Publisher   View Abstract

55.    Hyperphosphatemia is associated with overt proteinuria in non-diabetic patients with late-stage chronic kidney disease: a cross-sectional study
Yap, Yit-Sheung; Chi, Wen-Che; Lin, Cheng-Hao; et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY  Volume: 45   Issue: 1   Pages: 163-172   Published: FEB 2013
 from Publisher   View Abstract

56.    A Physiologic-Based Approach to the Evaluation of a Patient With Hyperphosphatemia
Leaf, David E.; Wolf, Myles
AMERICAN JOURNAL OF KIDNEY DISEASES  Volume: 61   Issue: 2   Pages: 330-336   Published: FEB 2013
 from Publisher   View Abstract

57.    Growth-associated hyperphosphatemia in young recipients accelerates aortic allograft calcification in a rat model
Yamauchi, Haruo; Motomura, Noboru; Chung, Ung-il; et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY  Volume: 145   Issue: 2   Pages: 522-530   Published: FEB 2013
 from Publisher   View Abstract

58.    Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherence
Jesus Lloret, Ma; Ruiz-Garcia, Cesar; DaSilva, Iara; et al.
PATIENT PREFERENCE AND ADHERENCE  Volume: 7   Pages: 1147-1156   Published: 2013
 from Publisher   View Abstract

59.    Economic evaluation of sevelamer for the treatment of hyperphosphatemia in chronic kidney disease patients not on dialysis in the United Kingdom.
Thompson, Melissa; Bartko-Winters, Susan; Bernard, Lisa; et al.
Journal of medical economics  Volume: 16   Issue: 6   Pages: 744-55   Published: 2013 (Epub 2013 Apr 17)
 from Publisher   View Abstract

60.    Effects and safety of lanthanum carbonate in end stage renal disease patients with hyperphosphatemia: a meta-analysis - system review of lanthanum carbonate
Guo, Hua; Zhang, Xiaojuan; Tang, Shaowen; et al.
RENAL FAILURE  Volume: 35   Issue: 10   Pages: 1455-1464   Published: 2013
 from Publisher   View Abstract

61.    A modeled economic evaluation of sevelamer for treatment of hyperphosphatemia associated with chronic kidney disease among patients on dialysis in the United Kingdom.
Bernard, Lisa; Mendelssohn, David; Dunn, Elizabeth; et al.
Journal of medical economics  Volume: 16   Issue: 1   Pages: 1-9   Published: 2013 (Epub 2012 Sep 10)
 from Publisher   View Abstract

62.    Preparation and Characterization of Lanthanum Carbonate Octahydrate for the Treatment of Hyperphosphatemia
He, Anqi; Zhou, Fengshan; Ye, Fang; et al.
JOURNAL OF SPECTROSCOPY    Article Number: UNSP 593636   Published: 2013
 from Publisher   View Abstract

63.    Should hyperphosphatemia be treated in 2012? And how?
Hummel, A.; Frantzen, L.; Jaubert, D.
NEPHROLOGIE & THERAPEUTIQUE  Volume: 8   Special Issue: 2   Pages: 5-9   Published: DEC 2012

64.    Spurious Hyperphosphatemia: A Case for Caution
Aiyer, Ravi; Kazory, Amir
AMERICAN JOURNAL OF KIDNEY DISEASES  Volume: 60   Issue: 6   Pages: 1050-1051   Published: DEC 2012

65.    Npt2b Deletion Attenuates Hyperphosphatemia Associated with CKD
Schiavi, Susan C.; Tang, Wen; Bracken, Christina; et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY  Volume: 23   Issue: 10   Pages: 1691-1700   Published: OCT 2012
 from Publisher   View Abstract

66.    [Hyperphosphatemia and cardiovascular diseases : impact of vascular calcification and endothelial dysfunction].
Iijima, Katsuya
Clinical calcium  Volume: 22   Issue: 10   Pages: 1505-13   Published: 2012-Oct
  View Abstract

67.    Highly Selective and Low-swelling Phosphate-binding Polymer for Hyperphosphatemia Therapy
Inoue, Atsushi; Minakami, Satoshi; Kanno, Takami; et al.
CHEMISTRY LETTERS  Volume: 41   Issue: 9   Pages: 932-933   Published: SEP 5 2012
 from Publisher   View Abstract

68.    Calcium carbonate compositions for preventing or treating hyperphosphatemia
Patent Number: US 08257750
Patent Assignee: Kibow Biotech Inc
Inventor(s): Ranganathan, Natarajan.
Official Gazette of the United States Patent and Trademark Office Patents  Published: SEP 4 2012
  View Abstract

69.    Hyperphosphatemia in a Patient with Respiratory Problems
Toutkaboni, Mihan Pourabdollah; Taheri, Zohreh Mohammad; Mohammadi, Forouzan; et al.
LABMEDICINE  Volume: 43   Issue: 6   Pages: 291-293   Published: FAL 2012
 from Publisher   View Abstract

70.    L'iperfosforemia nell'insufficienza renale cronica di grado moderato: un paradosso della nefrologia moderna.
[Hyperphosphatemia in moderate CKD: a paradox of modern nephrology].
Bellasi, Antonio
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia  Volume: 29   Issue: 5   Pages: 519   Published: 2012 Sep-Oct

71.    Severe hyperphosphatemia after administration of sodium-phosphate containing laxatives in children: case series and systematic review of literature
Ladenhauf, Hannah N.; Stundner, Ottokar; Spreitzhofer, Florian; et al.
PEDIATRIC SURGERY INTERNATIONAL  Volume: 28   Issue: 8   Pages: 805-814   Published: AUG 2012
 from Publisher   View Abstract

72.    Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Dialysis Patients: A Canadian Payer Perspective
Vegter, Stefan; Tolley, Keith; Keith, Michael S.; et al.
CLINICAL THERAPEUTICS  Volume: 34   Issue: 7   Pages: 1531-1543   Published: JUL 2012
 from Publisher   View Abstract

73.    HYPERPHOSPHATEMIA - THE RISK FACTOR FOR ADVERSE OUTCOME IN MAINTENANCE HEMODIALYSIS PATIENTS
Petrovic, Dejan; Obrenovic, Radmila; Trbojevic-Stankovic, Jasna; et al.
JOURNAL OF MEDICAL BIOCHEMISTRY  Volume: 31   Issue: 3   Pages: 239-245   Published: JUL-SEP 2012
 from Publisher   View Abstract

74.    Dietary intervention focused on phosphate intake in hemodialysis patients with hyperphosphatemia
Lou, L. M.; Caverni, A.; Gimeno, J. A.; et al.
Group Author(s): Aragon CKD Res Grp
CLINICAL NEPHROLOGY  Volume: 77   Issue: 6   Pages: 476-483   Published: JUN 2012
 from Publisher   View Abstract

75.    A MANAGED CARE COST-OFFSET MODEL FOR FERRIC CITRATE, AN EXPERIMENTAL PHOSPHATE BINDER THAT CAN REDUCE THE USE OF ERYTHROPOIESIS-STIMULATING AGENTS AND INTRAVENOUS IRON IN HEMODIALYSIS PATIENTS WITH HYPERPHOSPHATEMIA
Mutell, R.; Rubin, J. L.; Bond, T. C.; et al.
VALUE IN HEALTH  Volume: 15   Issue: 4   Pages: A155-A155   Published: JUN 2012

76.    RELATIONSHIP OF KT/VM AND PROTEIN CATABOLIC RATE WITH HYPERPHOSPHATEMIA IN PATIENTS UNDER CHRONIC HEMODIALYSIS
Marka-Castro, Edwin; Torres Zamora, Manuel Ignacio; Giron-Mino, Juan; et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION  Volume: 27   Supplement: 2   Pages: 198-198   Published: MAY 2012

77.    PILL BURDEN AND ITS ASSOCIATION WITH MEDICATION POSSESSION RATIO AMONG HEMODIALYSIS PATIENTS WITH HYPERPHOSPHATEMIA
Bond, Christopher; Wang, Steven; Alfieri, Thomas; et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION  Volume: 27   Supplement: 2   Pages: 280-280   Published: MAY 2012

78.    HYPERPHOSPHATEMIA DIRECTLY AFFECTS ENDOTHELIAL FUNCTION BY DOWN-REGULATING ANNEXIN II
Marco, Giovanna Seno D. I.; Koenig, Maximilian; Stock, Christian; et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION  Volume: 27   Supplement: 2   Pages: 441-441   Published: MAY 2012

79.    A META-ANALYSIS OF FERRIC CITRATE FOR HYPERPHOSPHATEMIA: THE EFFECTS OF AN ORAL IRON-CONTAINING PHOSPHATE BINDER ON SERUM FERRITIN AND SATURATED TRANSFERRIN IN HEMODIALYSIS PATIENTS
Bond, Christopher; Jensen, Donna; Wang, Steven; et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION  Volume: 27   Supplement: 2   Pages: 490-490   Published: MAY 2012

80.    Stanniocalcin 2 is associated with ectopic calcification in alpha-klotho mutant mice and inhibits hyperphosphatemia-induced calcification in aortic vascular smooth muscle cells
Takei, Yuichiro; Yamamoto, Hironori; Sato, Tadatoshi; et al.
BONE  Volume: 50   Issue: 4   Pages: 998-1005   Published: APR 2012
 from Publisher   View Abstract

81.    Combined therapy with lanthanum carbonate and calcium carbonate for hyperphosphatemia decreases serum FGF-23 level independently of calcium and PTH (COLC Study)
Shigematsu, Takashi; Negi, Shigeo
Group Author(s): COLC Res Grp
NEPHROLOGY DIALYSIS TRANSPLANTATION  Volume: 27   Issue: 3   Pages: 1050-1054   Published: MAR 2012
 from Publisher   View Abstract

82.    The effects of applying the transtheoretical model for behavioural correction in hyperphosphatemia
Chen, Y. H.; Peng, H. L.; Chen, Y. L.
INTERNATIONAL JOURNAL OF NURSING PRACTICE  Volume: 18   Special Issue: SI   Supplement: 1   Pages: 143-144   Published: FEB 2012

83.    Effect of Oral JTT-751 (Ferric Citrate) on Hyperphosphatemia in Hemodialysis Patients: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
Yokoyama, Keitaro; Hirakata, Hideki; Akiba, Takashi; et al.
AMERICAN JOURNAL OF NEPHROLOGY  Volume: 36   Issue: 5   Pages: 478-487   Published: 2012
 from Publisher   View Abstract

84.    Effects of Phosphonoformic Acid and Renagel on Renal Type IIa Sodium-Dependent Phosphate Cotransporter mRNA Expression in Hyperphosphatemia Rats
Zeng, Ming; Wang, Xiaoyun; Wang, Xiaobing; et al.
RENAL FAILURE  Volume: 34   Issue: 3   Pages: 358-363   Published: 2012
 from Publisher   View Abstract

85.    Hyperphosphatemia during spontaneous tumor lysis syndrome culminate in severe hypophosphatemia at the time of blast crisis of Phneg CML to acute myelomoncytic leukemia.
Salomon, Ophira; Holtzman, Eli J; Beckerman, Pazit; et al.
Experimental hematology & oncology  Volume: 1   Issue: 1   Pages: 24   Published: 2012 Aug 29
 from Publisher   View Abstract

86.    The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients.
Shigematsu, Takashi; Nakashima, Yuri; Ohya, Masaki; et al.
International journal of nephrology and renovascular disease  Volume: 5   Pages: 81-9   Published: 2012 (Epub 2012 May 29)
 from Publisher   View Abstract

87.    Cost-Effectiveness of Lanthanum Carbonate versus Sevelamer Hydrochloride for the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease: A US Payer Perspective
Park, Haesuk; Rascati, Karen L.; Keith, Michael S.; et al.
VALUE IN HEALTH  Volume: 14   Issue: 8   Pages: 1002-1009   Published: DEC 2011
 from Publisher   View Abstract

88.    Hyperphosphatemia and Hypozincemia Aggravated Hypertension and Cardiac Dysfunction in SHR/NDmcr-cp, a Model of Metabolic Syndrome
Suzuki, Yuka; Yamaguchi, Takanori; Kato, Ai; et al.
CIRCULATION  Volume: 124   Issue: 21   Supplement: S   Meeting Abstract: A16743   Published: NOV 22 2011
  View Abstract

89.    Hyperphosphatemia Causes Endothelial Dysfunction by Inhibiting Akt-Endothelial Nitric Oxide Synthase Pathway in Chronic Kidney Disease Rats
Taketani, Yutaka; Van, Tan Vu; Watari, Eriko; et al.
CIRCULATION  Volume: 124   Issue: 21   Supplement: S   Meeting Abstract: A10044   Published: NOV 22 2011
  View Abstract

90.    Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysis.
Vasantha, J; Soundararajan, P; Vanitharani, N; et al.
Indian journal of nephrology  Volume: 21   Issue: 4   Pages: 245-9   Published: 2011-Oct
 from Publisher   View Abstract

91.    Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Chronic Kidney Disease Before and During Dialysis
Vegter, Stefan; Tolley, Keith; Keith, Michael S.; et al.
VALUE IN HEALTH  Volume: 14   Issue: 6   Pages: 852-858   Published: SEP-OCT 2011
 from Publisher   View Abstract

92.    The association of vitamin D use with hypercalcemia and hyperphosphatemia in hemodialysis patients: a case-crossover study
Kilpatrick, Ryan D.; Danese, Mark D.; Belozeroff, Vasily; et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY  Volume: 20   Issue: 9   Pages: 914-921   Published: SEP 2011
 from Publisher   View Abstract

93.    HYPOPHOSPHATEMIA AND HYPERPHOSPHATEMIA ASSOCIATED WITH INCREASED MORTALITY IN INCIDENT AUSTRALIAN AND NEW ZEALAND DIALYSIS PATIENTS
Toussaint, N. D.; Mcdonald, S. P.; Walker, R. G.; et al.
NEPHROLOGY  Volume: 16   Supplement: 1   Pages: 26-27   Meeting Abstract: 011   Published: SEP 2011

94.    Sirtuin 1 Retards Hyperphosphatemia-Induced Calcification of Vascular Smooth Muscle Cells
Takemura, Aya; Iijima, Katsuya; Ota, Hidetaka; et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY  Volume: 31   Issue: 9   Pages: 2054-U370   Published: SEP 2011
 from Publisher   View Abstract

95.    Alteplase as hemodialysis catheter locking solution and spurious hyperphosphatemia
Sombolos, Kostas; Bamichas, Gerasimos; Hatsiou, Victoria; et al.
JOURNAL OF VASCULAR ACCESS  Volume: 12   Issue: 3   Pages: 269-269   Published: JUL-SEP 2011

96.    Lower body weight and female gender: Hyperphosphatemia risk factors after sodium phosphate preparations
Deepak, Parakkal; Ehrenpreis, Eli D.
WORLD JOURNAL OF GASTROENTEROLOGY  Volume: 17   Issue: 21   Pages: 2681-2682   Published: JUN 7 2011

97.    Lower body weight and female gender: Hyperphosphatemia risk factors after sodium phosphate preparations
Deepak, Parakkal; Ehrenpreis, Eli D.
WORLD JOURNAL OF GASTROENTEROLOGY  Volume: 17   Issue: 21   Pages: 2681-2681   Published: JUN 7 2011
 from Publisher   View Abstract

98.    Lower body weight and female gender: hyperphosphatemia risk factors after sodium phosphate preparations.
Deepak, Parakkal; Ehrenpreis, Eli D
World journal of gastroenterology : WJG  Volume: 17   Issue: 21   Pages: 2681-2   Published: 2011-Jun-7
 from Publisher   View Abstract

99.    A Case of Severe Hyperphosphatemia and Hypocalcemia Caused by Bowel Preparation for Colonoscopy using Small Amounts of Oral Sodium Phosphate in End-stage Renal Disease
Park, Ji Hoon; Lee, Sang Wook; Kim, Young Jae; et al.
Chung-Ang Journal of Medicine  Volume: 36   Issue: 1-2   Pages: 29-33   Published: JUN 2011
  View Abstract

100.    Controle da hiperfosfatemia na DRC
Management of hyperphosphatemia in CKD
Carvalho, Aluizio Barbosa de; Cuppari, Lilian
Jornal Brasileiro de Nefrologia  Volume: 33   Issue: 2   Pages: 189-247   Published: 2011-06

101.    THE COST-EFFECTIVENESS OF LANTHANUM CARBONATE IN THE TREATMENT OF HYPERPHOSPHATEMIA IN DIALYSIS PATIENTS FROM A CANADIAN PERSPECTIVE
Vegter, S.; Tolley, K.; Levin, A.; et al.
VALUE IN HEALTH  Volume: 14   Issue: 3   Pages: A77-A77   Published: MAY 2011

102.    LANTHANUM CARBONATE (LC) VS SEVELAMER FOR TREATING HYPERPHOSPHATEMIA IN CKD
Copley, J. Brian; Pratt, Raymond; Martin, Patrick; et al.
AMERICAN JOURNAL OF KIDNEY DISEASES  Volume: 57   Issue: 4   Pages: A33-A33   Meeting Abstract: 68   Published: APR 2011

103.    Effect of Lanthanum Carbonate Treatment on Bone in Japanese Dialysis Patients With Hyperphosphatemia
Shigematsu, Takashi; Tokumoto, Akihide; Nakaoka, Akihisa; et al.
THERAPEUTIC APHERESIS AND DIALYSIS  Volume: 15   Issue: 2   Pages: 176-184   Published: APR 2011
 from Publisher   View Abstract

104.    Controle da hiperfosfatemia na DRC.
[Management of hyperphosphatemia in CKD].
de Carvalho, Aluizio Barbosa; Cuppari, Lilian
Corporate Author(s): Sociedade Brasileira de Nefrologia
Jornal brasileiro de nefrologia : ʹorgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia  Volume: 33 Suppl 1   Pages: 1-6   Published: 2011-Apr

105.    Controle da hiperfosfatemia na DRC.
[Management of hyperphosphatemia in CKD].
de Carvalho, Aluizio Barbosa; Cuppari, Lilian
Corporate Author(s): Sociedade Brasileira de Nefrologia
Jornal brasileiro de nefrologia : ʹorgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia  Volume: 33   Issue: 2   Pages: 191-6   Published: 2011 Apr-Jun

106.    Hyperphosphatemia in pediatric oncology patients receiving liposomal amphotericin B.
Knoderer, Chad A; Knoderer, Holly M
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG  Volume: 16   Issue: 2   Pages: 87-91   Published: 2011-Apr
 from Publisher   View Abstract

107.    Mutations in GALNT3 GENE: Two adolescents with tumoral calcinosis-hyperphosphatemia
Falcini, F.; Masi, L.; Cavalli, L.; et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY  Volume: 29   Issue: 2   Pages: 379-380   Published: MAR-APR 2011

108.    Prevention of systemic and regional haemodynamic alterations, hypercreatininemia, hyperuremia and hyperphosphatemia by losartan in hypertension with acute renal failure
Ivanov, M.; Mihailovic-Stanojevic, N.; Milanovic, J. Grujic; et al.
ACTA PHYSIOLOGICA HUNGARICA  Volume: 98   Issue: 1   Pages: 1-7   Published: MAR 2011
 from Publisher   View Abstract

109.    Physicochemical Characterization of La-2(CO3)(3)center dot 4H(3)O, a New and Promising Agent for the Treatment of Hyperphosphatemia
Baran, Enrique J.
LATIN AMERICAN JOURNAL OF PHARMACY  Volume: 30   Issue: 1   Pages: 126-131   Published: FEB 2011
  View Abstract

110.    Prevention and Control of Phosphate Retention/Hyperphosphatemia in CKD-MBD: What Is Normal, When to Start, and How to Treat?
Martin, Kevin J.; Gonzalez, Esther A.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY  Volume: 6   Issue: 2   Pages: 440-446   Published: FEB 2011
 from Publisher   View Abstract

111.    A 90-Year-Old Man With Hyperphosphatemia
Lovekar, Shachi; Chen, Joline L. T.
AMERICAN JOURNAL OF KIDNEY DISEASES  Volume: 57   Issue: 2   Pages: 342-346   Published: FEB 2011
 from Publisher   View Abstract

112.    Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro
Sage, Andrew P.; Lu, Jinxiu; Tintut, Yin; et al.
KIDNEY INTERNATIONAL  Volume: 79   Issue: 4   Pages: 414-422   Published: FEB 2011
 from Publisher   View Abstract

113.    Effect of Short-Term Low-Protein Diet Supplemented with Keto Acids on Hyperphosphatemia in Maintenance Hemodialysis Patients
Li, Haiming; Long, Quan; Shao, Chunhai; et al.
BLOOD PURIFICATION  Volume: 31   Issue: 1-3   Pages: 33-40   Published: 2011
 from Publisher   View Abstract

114.    New-onset headache in an elderly man with uremia that improved only after correction of hyperphosphatemia ("uremic headache"): a case report.
Razdan, Sushil; Pandita, Kk; Chopra, Vanilla; et al.
Journal of medical case reports  Volume: 5   Pages: 77   Published: 2011 Feb 24
 from Publisher   View Abstract

115.    Reduction of Hyperphosphatemia is Related with the Reduction of C-Reactive Protein in Dialysis Patients. Study in Sevelamer-Resistant Dialysis Patients Treated with Chitosan Chewing Gum as Salivary Phosphate Binder
Calo, Lorenzo A.; Savica, Vincenzo; Piccoli, Antonio; et al.
RENAL FAILURE  Volume: 33   Issue: 1   Pages: 11-14   Published: 2011
 from Publisher   View Abstract

116.    How KDIGO Will (or Will Not) Influence the Management of Hyperphosphatemia
Kovesdy, Csaba P.
SEMINARS IN DIALYSIS  Volume: 24   Issue: 1   Pages: 35-36   Published: JAN-FEB 2011

117.    Erroneous determination of hyperphosphatemia ('pseudohyperphosphatemia') in sera of patients that have been treated with liposomal amphotericin B (AmBisome)
Jensen, Gerard M.; Bunch, Tarquinus H.; Wolf, Steven; et al.
CLINICA CHIMICA ACTA  Volume: 411   Issue: 23-24   Pages: 1900-1905   Published: DEC 14 2010
 from Publisher   View Abstract

118.    Phosphoproteomic Analysis in the Endothelial Cells Damaged by Hyperphosphatemia
Kitamura, Tomoyo; Taketani, Yutaka; Watari, Eriko; et al.
CIRCULATION  Volume: 122   Issue: 21   Supplement: S   Meeting Abstract: A18953   Published: NOV 23 2010
  View Abstract

119.    Extended Release Niacin/Laropiprant Lowers Serum Phosphorus Concentrations in Patients with Type 2 Diabetes and Mild Hyperphosphatemia
Bostom, Andrew G.; MacLean, Alexandra A.; Maccubbin, Darbie; et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY  Volume: 30   Issue: 11   Pages: E200-E200   Published: NOV 2010

120.    [Treatment of hyperphosphatemia with sevelamer hydrochloride in CKD patients: effects on vascular calcification and mortality].
Koizumi, Masahiro; Fukagawa, Masafumi
Clinical calcium  Volume: 20   Issue: 11   Pages: 1700-8   Published: 2010-Nov
 from Publisher   View Abstract

121.    Sevelamer carbonate for the treatment of hyperphosphatemia in patients with kidney failure (CKD III-V)
Biggar, Patrick; Ketteler, Markus
EXPERT OPINION ON PHARMACOTHERAPY  Volume: 11   Issue: 16   Pages: 2739-2750   Published: NOV 2010
 from Publisher   View Abstract

122.    Terapia dell'iperfosforemia nei pazienti in trattamento dialitico: ruolo dei chelanti del fosforo.
[Management of hyperphosphatemia in dialysis patients: the role of phosphate binders].
Malberti, Fabio
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia  Volume: 27 Suppl 52   Pages: S47-54   Published: 2010 Nov-Dec
  View Abstract

123.    EFFICACY OF PHOSPHATE BINDER SEVELAMER IN CHILDREN WITH HYPERPHOSPHATEMIA DUE TO TUMOR LYSIS SYNDROME
Kahlon, Dilraj; Dinand, Veronique; Bhat, Sunil; et al.
PEDIATRIC BLOOD & CANCER  Volume: 55   Issue: 5   Pages: 953-953   Published: NOV 2010

124.    Increased extraosseus 99m-technetium hydroxy diphosphonate uptake in chronic kidney disease patients with secondary hyperparathyroidism. Correlation with hyperphosphatemia
Enevoldsen, L. H.; Heaf, J.; Hasbak, P.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING  Volume: 37   Supplement: 2   Pages: S471-S471   Published: OCT 2010

125.    Flow-through peritoneal dialysis in neonatal enema-induced hyperphosphatemia
Kostic, Dusan; Dutra Rodrigues, Andre Broggin; Leal, Antonio; et al.
PEDIATRIC NEPHROLOGY  Volume: 25   Issue: 10   Pages: 2183-2186   Published: OCT 2010
 from Publisher   View Abstract

126.    Self-Adjustment of Phosphate Binder Dose to Meal Phosphorus Content Improves Management of Hyperphosphatemia in Children with Chronic Kidney Disease (CKD)
Ahlenstiel, T.; Pape, L.; Ehrich, J. H. H.; et al.
PEDIATRIC NEPHROLOGY  Volume: 25   Issue: 9   Pages: 1906-1906   Meeting Abstract: 555   Published: SEP 2010

127.    Enema-Induced Hyperphosphatemia in a Newborn - Clinical Experience with Flow-Through Peritoneal Dialysis
Koch, V.; Kostic, D.; Metran, C.
PEDIATRIC NEPHROLOGY  Volume: 25   Issue: 9   Pages: 1941-1941   Meeting Abstract: 734   Published: SEP 2010

128.    PA21: a novel phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease
Geisser, P.; Philipp, E.
CLINICAL NEPHROLOGY  Volume: 74   Issue: 1   Pages: 4-11   Published: JUL 2010
  View Abstract

129.    Hyperphosphatemia: understanding the role of phosphate metabolism.
Podd, Daniel
JAAPA : official journal of the American Academy of Physician Assistants  Volume: 23   Issue: 7   Pages: 32-7   Published: 2010-Jul

130.    Overexpression of parathyroid pituitary-specific transcription factor (Pit)-1 in hyperphosphatemia-induced hyperparathyroidism of chronic renal failure rats
Jiang Ying; Wang Mei
CHINESE MEDICAL JOURNAL  Volume: 123   Issue: 12   Pages: 1566-1570   Published: JUN 20 2010
 from Publisher   View Abstract

131.    Hyperphosphatemia in a 56-Year-Old Man with Hypochondrial Pain
Loh, Tze Ping; Saw, Sharon; Sethi, Sunil Kumar
CLINICAL CHEMISTRY  Volume: 56   Issue: 6   Pages: 892-895   Published: JUN 2010

132.    Hyperphosphatemia in a 56-Year-Old Man with Hypochondrial Pain Commentary
Roy, Vivek
CLINICAL CHEMISTRY  Volume: 56   Issue: 6   Pages: 895-896   Published: JUN 2010

133.    Hyperphosphatemia in a 56-Year-Old Man with Hypochondrial Pain Commentary
Endres, David B.
CLINICAL CHEMISTRY  Volume: 56   Issue: 6   Pages: 896-896   Published: JUN 2010

134.    Adherence and knowledge about hyperphosphatemia treatment in hemodialysis patients with hyperphosphatemia.
Nerbass, Fabiana B; Morais, Jyana G; dos Santos, Rafaela G; et al.
Jornal brasileiro de nefrologia : ʹorgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia  Volume: 32   Issue: 2   Pages: 149-55   Published: 2010 Apr-Jun
 from Publisher   View Abstract

135.    HYPERPHOSPHATEMIA IN CHILDREN RECEIVING LIPOSOMAL AMPHOTERICIN B
Knoderer, Holly; Ricci, Michelle; Knoderer, Chad
PEDIATRIC BLOOD & CANCER  Volume: 54   Issue: 6   Pages: 821-821   Published: JUN 2010

136.    Niacin as potential treatment for dyslipidemia and hyperphosphatemia associated with chronic renal failure: the need for clinical trials
Ahmed, Mohamed H.
RENAL FAILURE  Volume: 32   Issue: 5   Pages: 642-646   Published: 2010
 from Publisher   View Abstract

137.    HYPERPHOSPHATEMIA
Orrego, John J.; Sheehan, Michael
ENDOCRINE PRACTICE  Volume: 16   Issue: 3   Pages: 524-525   Published: MAY-JUN 2010

138.    MUTATIONS IN GALNT3 GENE: TWO CASES OF TUMORAL CALCINOSIS-HYPERPHOSPHATEMIA
Masi, L.; Franceschelli, F.; Gozzini, A.; et al.
OSTEOPOROSIS INTERNATIONAL  Volume: 21   Supplement: 1   Pages: 288-288   Published: MAY 2010

139.    CHALLENGES IN ASSESSING COST-EFFECTIVENESS OF THERAPIES FOR DIALYSIS PATIENTS: A CASE STUDY OF SEVELAMER FOR THE TREATMENT OF HYPERPHOSPHATEMIA
Grima, D.; Mendelssohn, D.; Airia, P.; et al.
VALUE IN HEALTH  Volume: 13   Issue: 3   Pages: A78-A78   Published: MAY 2010

140.    COST-EFFECTIVENESS OF SEVELAMER IN THE TREATMENT OF HYPERPHOSPHATEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE IN BRAZIL
Rivas, R.; Idrovo, J.; Zapata, L.
VALUE IN HEALTH  Volume: 13   Issue: 3   Pages: A210-A210   Published: MAY 2010

141.    COST-EFFECTIVENESS OF SEVELAMER IN THE TREATMENT OF HYPERPHOSPHATEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE IN ARGENTINA
Rivas, R.; Idrovo, J.; Zapata, L.
VALUE IN HEALTH  Volume: 13   Issue: 3   Pages: A210-A210   Published: MAY 2010

142.    Phosphonic acid derivatives and the treating agents of diseases related hyperphosphatemia
Patent Number: US 07691898
Patent Assignee: Kotobuki Pharmaceutical Co Ltd
Inventor(s): Tomiyama, Hiroshi; Yokota, Masayuki; Tokuzaki, Kazuo; et al.
Official Gazette of the United States Patent and Trademark Office Patents  Published: APR 6 2010
  View Abstract

143.    STRATEGIES To IMPROVE PHOSPHORUS CONTROL IN PATIENTS CHRONIC SEVERE HYPERPHOSPHATEMIA
Clark, Barbara; Patel, Ankur; Groves-Seaman, Lori; et al.
AMERICAN JOURNAL OF KIDNEY DISEASES  Volume: 55   Issue: 4   Pages: A49-A49   Meeting Abstract: 71   Published: APR 2010

144.    A COST-EFFECTIVENESS MODEL OF PHOSPHATE BINDERS FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE (CKD)
Keith, Michael; Smyth, Michael; Carlton, Rashad; et al.
AMERICAN JOURNAL OF KIDNEY DISEASES  Volume: 55   Issue: 4   Pages: A69-A69   Meeting Abstract: 152   Published: APR 2010

145.    Native vitamin D supplementation does not correct vitamin D status in chronic kidney disease patients: possible role of FGF 23 and hyperphosphatemia
Liabeuf, S.; Barreto, D.; Barreto, F.; et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY  Volume: 24   Supplement: 1   Pages: 39-39   Meeting Abstract: 188   Published: APR 2010

146.    Native vitamin D supplementation does not correct vitamin D status in chronic kidney disease patients : possible role of FGF 23 and hyperphosphatemia
Liabeuf, S.; Barreto, D.; Barreto, F.; et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY  Volume: 24   Supplement: 1   Pages: 46-47   Meeting Abstract: 226   Published: APR 2010

147.    Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia
Prosdocimo, Domenick A.; Wyler, Steven C.; Romani, Andrea M.; et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY  Volume: 298   Issue: 3   Pages: C702-C713   Published: MAR 2010
 from Publisher   View Abstract

148.    Hyperphosphatemia induced by high phosphate-adenine diet progresses nephrotic syndrome in type III Na-dependent phosphate transporter over-expressing rats
Sekiguchi, Sahoko; Shibata, Megumi; Asano, Shougo; et al.
ENDOCRINE JOURNAL  Volume: 57   Supplement: 2   Pages: S493-S494   Published: MAR 2010

149.    Severe hyperphosphatemia and symptomatic hypocalcemia after bowel cleansing with oral sodium phosphate solution in a patient with postoperative hypoparathyroidism
Berker, Dilek; Isik, Serhat; Aydin, Yusuf; et al.
CENTRAL EUROPEAN JOURNAL OF MEDICINE  Volume: 5   Issue: 1   Pages: 65-68   Published: FEB 2010
 from Publisher   View Abstract

150.    Targeting hyperphosphatemia: truth or dare
Meijers, Bjorn; Evenepoel, Pieter
KIDNEY INTERNATIONAL  Volume: 77   Issue: 3   Pages: 256-257   Published: FEB 2010

151.    Response to 'Targeting hyperphosphatemia: truth or dare'
Isakova, Tamara; Gutierrez, Orlando M.; Wolf, Myles
KIDNEY INTERNATIONAL  Volume: 77   Issue: 3   Pages: 257-257   Published: FEB 2010

152.    One Year Efficacy and Safety of Lanthanum Carbonate for Hyperphosphatemia in Japanese Chronic Kidney Disease Patients Undergoing Hemodialysis
Shigematsu, Takashi
Group Author(s): Lanthanum Carbonate Res Grp
THERAPEUTIC APHERESIS AND DIALYSIS  Volume: 14   Issue: 1   Pages: 12-19   Published: FEB 2010
 from Publisher  

153.    The Control of Hyperphosphatemia in Renal Failure: Between Vascular Calcification and Inflammation
Cozzolino, Mario
BLOOD PURIFICATION  Volume: 30   Issue: 3   Pages: 159-160   Published: 2010

154.    Hyperphosphatemia after sodium phosphate laxatives in low risk patients: Prospective study
Noemi Casais, Marcela; Rosa-Diez, Guillermo; Perez, Susana; et al.
WORLD JOURNAL OF GASTROENTEROLOGY  Volume: 15   Issue: 47   Pages: 5960-5965   Published: DEC 21 2009
 from Publisher  

155.    Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model
Nakatani, Teruyo; Ohnishi, Mutsuko; Razzaque, M. Shawkat
FASEB JOURNAL  Volume: 23   Issue: 11   Pages: 3702-3711   Published: NOV 2009
 from Publisher  

156.    TREATMENT OPTIONS FOR HYPERPHOSPHATEMIA IN FELINE CKD What's out there?
Kidder, Aimee; Chew, Dennis
JOURNAL OF FELINE MEDICINE AND SURGERY  Volume: 11   Issue: 11   Pages: 913-924   Published: NOV 2009
 from Publisher  

157.    Severe Hyperphosphatemia in a Newborn With Renal Insufficiency Because of an Erroneous Medical Prescription
Dissaneewate, Supaporn; Vachvanichsanong, Prayong
JOURNAL OF RENAL NUTRITION  Volume: 19   Issue: 6   Pages: 500-502   Published: NOV 2009
 from Publisher  

158.    THE COST-EFFECTIVENESS OF PHOSPHATE BINDERS FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE (CKD)
Keith, M. S.; Carlton, R.; Meissner, B. L.
VALUE IN HEALTH  Volume: 12   Issue: 7   Pages: A309-A309   Published: OCT 2009

159.    Rare earth metal compositions for treating hyperphosphatemia and related methods
Patent Number: US 07588782
Patent Assignee: Altairnano Inc
Inventor(s): Moerck, Rudi E.; Spitler, Timothy Malcome; Schauer, Edward A.; et al.
Official Gazette of the United States Patent and Trademark Office Patents  Published: SEP 15 2009

160.    Reply to correspondence letter: enema-induced severe hyperphosphatemia in children
Biebl, A.
EUROPEAN JOURNAL OF PEDIATRICS  Volume: 168   Issue: 8   Pages: 1021-1021   Published: AUG 2009

161.    RE: Enema-induced severe hyperphosphatemia in children
Caswell, Michael
EUROPEAN JOURNAL OF PEDIATRICS  Volume: 168   Issue: 8   Pages: 1023-1023   Published: AUG 2009

162.    Effect of lanthanum carbonate and calcium acetate in the treatment of hyperphosphatemia in patients of chronic kidney disease
Scaria, P. Thomas; Gangadhar, Reneega; Pisharody, Ramdas
INDIAN JOURNAL OF PHARMACOLOGY  Volume: 41   Issue: 4   Pages: 187-191   Published: JUL-AUG 2009
 from Publisher  

163.    Il controllo della fosforemia nell'insufficienza renale cronica.
[Management of hyperphosphatemia in patients with chronic kidney disease].
Savica, V; Santoro, D; Monardo, P; et al.
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia  Volume: 26 Suppl 46   Pages: 58-61   Published: 2009 Jul-Aug

164.    A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features
Dumitrescu, C. E.; Kelly, M. H.; Khosravi, A.; et al.
OSTEOPOROSIS INTERNATIONAL  Volume: 20   Issue: 7   Pages: 1273-1278   Published: JUL 2009
 from Publisher  

165.    [Clinical aspect of recent progress in phosphate metabolism. Hyperphosphatemia and hypophosphatemia].
Michigami, Toshimi
Clinical calcium  Volume: 19   Issue: 6   Pages: 785-92   Published: 2009-Jun
 from Publisher  

166.    Pill Burden, Adherence, Hyperphosphatemia, and Quality of Life in Maintenance Dialysis Patients
Chiu, Yi-Wen; Teitelbaum, Isaac; Misra, Madhukar; et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY  Volume: 4   Issue: 6   Pages: 1089-1096   Published: JUN 2009
 from Publisher  

167.    Ablation of the Galnt3 Gene Leads to Low-Circulating Intact Fibroblast Growth Factor 23 (Fgf23) Concentrations and Hyperphosphatemia Despite Increased Fgf23 Expression
Ichikawa, Shoji; Sorenson, Andrea H.; Austin, Anthony M.; et al.
ENDOCRINOLOGY  Volume: 150   Issue: 6   Pages: 2543-2550   Published: JUN 2009
 from Publisher  

168.    The Case Metabolic disarray after fire extinguisher powder ingestion The Diagnosis Fire extinguisher powder ingestion with hyperphosphatemia and hypocalcemia
Lin, Cheng-Jui; Chen, Han-Hsiang; Chang, Kuo-Song; et al.
KIDNEY INTERNATIONAL  Volume: 75   Issue: 9   Pages: 993-994   Published: MAY 2009

169.    Akut hyperfosfataemi hos en dialysepatient efter indgift af fosfatklyx.
[Acute hyperphosphatemia in a dialysis patient after administration of sodium phosphate].
Azad, Brian Behfar Sohrabi; Cordtz, Joakim
Ugeskrift for laeger  Volume: 171   Issue: 17   Pages: 1414   Published: 2009-Apr-20

170.    Pathogenesis of bone and mineral related disorders in chronic kidney disease: key role of hyperphosphatemia.
Roman-Garcia, Pablo; Carrillo-Lopez, Natalia; Cannata-Andia, Jorge B
Journal of renal care  Volume: 35 Suppl 1   Pages: 34-8   Published: 2009-Mar
 from Publisher  

171.    Salivary Phosphorus Binding: A Novel Approach to Control Hyperphosphatemia
Eknoyan, Garabed
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY  Volume: 20   Issue: 3   Pages: 460-462   Published: MAR 2009

172.    Salivary Phosphate-Binding Chewing Gum Reduces Hyperphosphatemia in Dialysis Patients
Savica, Vincenzo; Calo, Lorenzo A.; Monardo, Paolo; et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY  Volume: 20   Issue: 3   Pages: 639-644   Published: MAR 2009
 from Publisher  

173.    Effect of Food Additives on Hyperphosphatemia Among Patients With End-stage Renal Disease A Randomized Controlled Trial
Sullivan, Catherine; Sayre, Srilekha S.; Leon, Janeen B.; et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION  Volume: 301   Issue: 6   Pages: 629-635   Published: FEB 11 2009
 from Publisher  

174.    Newly discovered mutations in the GALNT3 gene causing autosomal recessive hyperostosis-hyperphosphatemia syndrome
Gok, Faysal; Chefetz, Ilana; Indelman, Margarita; et al.
ACTA ORTHOPAEDICA  Volume: 80   Issue: 1   Pages: 131-134   Article Number: PII 909701055   Published: 2009
 from Publisher  

175.    Is It Worth Correcting Hyperparathyroidism if Hyperphosphatemia and Hypocalcemia Worsen? A Cinacalcet Story
Kalantar-Zadeh, Kamyar; Kovesdy, Csaba P.
AMERICAN JOURNAL OF KIDNEY DISEASES  Volume: 53   Issue: 2   Pages: 183-188   Published: FEB 2009

176.    [Roles of hyperphosphatemia in vascular calcification].
Shioi, Atsushi; Nishizawa, Yoshiki
Clinical calcium  Volume: 19   Issue: 2   Pages: 180-5   Published: 2009-Feb
 from Publisher  

177.    [Management of hyperphosphatemia ; phosphate-binder].
Yokoyama, Keitaro
Clinical calcium  Volume: 19   Issue: 2   Pages: 205-12   Published: 2009-Feb
 from Publisher  

178.    [To facilitate the compliance of phosphate binder for the control of hyperphosphatemia in chronic kidney disease patients].
Maruyama, Toru; Kadowaki, Daisuke
Clinical calcium  Volume: 19   Issue: 2   Pages: 248-52   Published: 2009-Feb
 from Publisher  

179.    Iron-Magnesium Hydroxycarbonate (Fermagate): A Novel Non-Calcium-Containing Phosphate Binder for the Treatment of Hyperphosphatemia in Chronic Hemodialysis Patients
McIntyre, Christopher W.; Pai, Pearl; Warwick, Graham; et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY  Volume: 4   Issue: 2   Pages: 401-409   Published: FEB 2009
 from Publisher  

180.    The control of hyperphosphatemia in chronic kidney disease: Which phosphate binder?
Ketteler, Markus
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS  Volume: 32   Issue: 2   Pages: 95-100   Published: FEB 2009

181.    Efficacy of hyperphosphatemia control in the progression of chronic renal failure and the prevalence of cardiovascular calcification
Lezaic, V.; Tirmenstajn-Jankovic, B.; Bukvic, D.; et al.
CLINICAL NEPHROLOGY  Volume: 71   Issue: 1   Pages: 21-29   Published: JAN 2009

182.    Enema-induced severe hyperphosphatemia in children
Biebl, Ariane; Grillenberger, Andrea; Schmitt, Klaus
EUROPEAN JOURNAL OF PEDIATRICS  Volume: 168   Issue: 1   Pages: 111-112   Published: JAN 2009
 from Publisher  

183.    Hypercalcemia and hyperphosphatemia secondary to subcutaneous fat necrosis of the newborn - case report
Rorato, Marilia G.; Santos, Maria Zeneide A.; Castro, Luiz Claudio G.; et al.
HORMONE RESEARCH  Volume: 72   Pages: 418-418   Published: 2009

184.    Management of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate.
Persy, Veerle P; Behets, Geert J; De Broe, Marc E; et al.
International journal of nephrology and renovascular disease  Volume: 2   Pages: 1-8   Published: 2009 (Epub 2009 Apr 01)

185.    Improvement of Hyperphosphatemia Following Patient Education
Satoh, Minori; Koizumi, Akiko; Izumi, Satoshi; et al.
Journal of Pharmacy Technology  Volume: 25   Issue: 1   Pages: 3-9   Published: JAN-FEB 2009

186.    Salivary Phosphorus and Phosphate Content of Beverages: Implications for the Treatment of Uremic Hyperphosphatemia
Savica, Vincenzo; Calo, Lorenzo A.; Monardo, Paolo; et al.
JOURNAL OF RENAL NUTRITION  Volume: 19   Issue: 1   Pages: 69-72   Published: JAN 2009
 from Publisher  

187.    Fatal latrogenic hyperphosphatemia.
Caswell, Michael
The Journal of the Kentucky Medical Association  Volume: 107   Issue: 1   Pages: 28   Published: 2009-Jan

188.    Prevention and Management of Hyperphosphatemia with Sevelamer in Canada: Health and Economic Consequences
Huybrechts, Krista F.; Caro, J. Jaime; O'Brien, Judith A.
VALUE IN HEALTH  Volume: 12   Issue: 1   Pages: 16-19   Published: JAN-FEB 2009
 from Publisher  

189.    Hyperphosphatemia-induced hyperparathyroidism in 5/6 nephrectomized rats: development of a new animal model
Jiang Ying; Wang Mei
CHINESE MEDICAL JOURNAL  Volume: 121   Issue: 23   Pages: 2440-2443   Published: DEC 5 2008

190.    The mechanisms of hyperphosphatemia-induced vascular calcification
Cozzolino, M.; Gallieni, M.; Brancaccio, D.
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS  Volume: 31   Issue: 12   Pages: 1002-1003   Published: DEC 2008

191.    Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival data
Frazao, Joao M.; Adragao, Teresa
KIDNEY INTERNATIONAL  Volume: 74   Supplement: 111   Pages: S38-S43   Published: DEC 2008
 from Publisher  

192.    Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients
Ramos, Ana M.; Albalate, Marta; Vazquez, Silvia; et al.
KIDNEY INTERNATIONAL  Volume: 74   Supplement: 111   Pages: S88-S93   Published: DEC 2008
 from Publisher  

193.    Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival data.
Frazao, Joao M; Adragao, Teresa
Kidney international. Supplement  Issue: 111   Pages: S38-43   Published: 2008-Dec
 from Publisher  

194.    Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients.
Ramos, Ana M; Albalate, Marta; Vazquez, Silvia; et al.
Kidney international. Supplement  Issue: 111   Pages: S88-93   Published: 2008-Dec
 from Publisher  

195.    Hyperphosphatemia in renal failure.
Robb, Meigan
RN  Volume: 71   Issue: 12   Pages: 26-30; quiz 31   Published: 2008-Dec

196.    HYPERPHOSPHATEMIA IN THE CALCIUM ACETATE RENAGEL EVALUATION-2 (CARE-2) STUDY
Bleyer, Anthony J.
AMERICAN JOURNAL OF KIDNEY DISEASES  Volume: 52   Issue: 5   Pages: 1024-1024   Published: NOV 2008

197.    IN REPLY TO 'HYPERPHOSPHATEMIA IN THE CALCIUM ACETATE RENAGEL EVALUATION-2 (CARE-2) STUDY' AND 'BINDER WARS'
Qunibi, Wajeh; Muenz, Larry R.; Diaz-Buxo, Jose A.
AMERICAN JOURNAL OF KIDNEY DISEASES  Volume: 52   Issue: 5   Pages: 1025-1025   Published: NOV 2008

198.    Multicenter prospective randomized, double-blind comparative study between lanthanum carbonate and calcium carbonate as phosphate binders in Japanese hemodialysis patients with hyperphosphatemia
Shigematsu, T.
Group Author(s): Lanthanum Carbonate Grp
CLINICAL NEPHROLOGY  Volume: 70   Issue: 5   Pages: 404-410   Published: NOV 2008

199.    Lanthanum Carbonate Treatment of Patients with Hyperphosphatemia Undergoing CAPD
Kawanishi, H.; Ishida, M.; Ishizaki, M.; et al.
Group Author(s): Lanthanum Carbonate Study Grp Japa
PERITONEAL DIALYSIS INTERNATIONAL  Volume: 28   Issue: 6   Pages: 673-675   Published: NOV-DEC 2008

200.    Management of Hyperphosphatemia Is an Important Novel Therapeutic Target In Chronic Heart Failure
Asanuma, Hiroshi; Asakura, Masanori; Kim, Jiyoong; et al.
CIRCULATION  Volume: 118   Issue: 18   Pages: S433-S434   Published: OCT 28 2008

0 comments:

All links posted here are collected from various websites. No video or powerpoint files are uploaded on this blog. If you are the original author and do not wish to display your content on this blog please Email me anandkumarreddy at gmail dot com I will remove it. The contents of this blog are meant for educational purpose and not for commercial use. If you use any content give due credit to the original author.

This site uses cookies from Google to deliver its services, to personalise ads and to analyse traffic. Information about your use of this site is shared with Google. By using this site, you agree to its use of cookies.

  © Blogger templates Newspaper III by Ourblogtemplates.com 2008

Back to TOP